Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,72 USD | -13,92% | -10,23% | -56,65% |
Omzet 2022 | 22,3 mln. 20,84 mln. | Omzet 2023 | 7,19 mln. 6,72 mln. | Marktkapitalisatie | 25,42 mln. 23,75 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -62 mln. -57,94 mln. | Nettowinst (verlies) 2023 | -50 mln. -46,72 mln. | EV/omzet 2022 | 2,66 x |
Nettoschuld 2022 | 48,89 mln. 45,69 mln. | Nettoschuld 2023 | 33,81 mln. 31,59 mln. | EV/omzet 2023 | 8,23 x |
K/w-verhouding 2022 |
-0,12
x | K/w-verhouding 2023 |
-0,33
x | Werknemers | 113 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 11,77% |
Recentste transcriptie over T2 Biosystems, Inc.
1 dag | -13,92% | ||
1 week | -10,23% | ||
Lopende maand | -9,33% | ||
1 maand | -8,72% | ||
3 maanden | -36,30% | ||
6 maanden | -47,79% | ||
Lopend jaar | -56,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 08-01-20 |
John Sprague
DFI | Director of Finance/CFO | 65 | 30-01-18 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 01-07-14 |
Seymour Liebman
BRD | Director/Board Member | 74 | 21-09-16 |
Robin Toft
BRD | Director/Board Member | 63 | 14-06-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 3,16 | +6,76% | 1 363 736 |
19-04-24 | 2,96 | -1,00% | 534 565 |
18-04-24 | 2,99 | +1,70% | 106 827 |
17-04-24 | 2,94 | -2,97% | 63 952 |
16-04-24 | 3,03 | +2,02% | 84 568 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-56,65% | 27,79 mln. | |
+8,35% | 209 mld. | |
+9,41% | 175 mld. | |
+11,75% | 131 mld. | |
+19,34% | 99,98 mld. | |
-0,84% | 61,12 mld. | |
+15,08% | 52,34 mld. | |
-2,10% | 46,5 mld. | |
+0,10% | 39,24 mld. | |
+11,50% | 38,47 mld. |